News and Announcements
04-Sep-2025
Macau Launches First New Drug Clinical Trial: Boehringer Ingelheim and MUST Clinical Trial Center Join Forces to Build a New Highland for Clinical Research in the Greater Bay Area
August 29, 2025 — The inauguration of Macau’s first new drug clinical trial, combined with the strategic partnership signing ceremony between Boehringer Ingelheim and the Clinical Trial Center of the Macau University of Science and Technology (MUST-CTC), was successfully held today at MUST. This event lays a solid foundation for the establishment of a comprehensive […] Read More
26-Jun-2025
Visit from GBA Center for Drug Evaluation and Inspection of NMPA
We are honoured to host the delegates from the GBA Center for Drug Evaluation and Inspection of NMPA on June 26, 2025. Featuring a productive knowledge exchange session where we discussed the latest advancements in clinical research regulation, another highlight was the introduction of ClinCluster® —a collaborative network initiated by HKU-CTC to enhance communication, resource […] Read More
19-Sep-2024
Contributing to advancing medical research and healthcare outcomes via Gleneagles Clinical Trials Centre
Gleneagles has launched its Gleneagles Clinical Trials Centre (Gleneagles CTC) on September 19, 2024, marking an important milestone in our commitment to advancing medical research and patient care. Co-managed by Gleneagles Hospital Hong Kong and HKU Clinical Trials Centre, Gleneagles CTC provides a platform for innovative discovery across the clinical research ecosystem and facilitates various […] Read More
20-May-2024
DIA China Annual Meeting 2024
DIA China Annual Meeting 2024 was successfully held from May 17-19, 2024 in Suzhou. The meeting brought together 6000+ drug development professionals and over 490+ exhibitors from global and local pharmaceutical companies, clinical study sites and clinical research organizations (CRO). HKU-CTC exhibited at the meeting where ClinCluster (科聯醫達) and eSMO+ (科聯醫港) have been officially launched. […] Read More




